We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
Study
Team
None available
prince-ssp@exeter.ac.uk
Prof
Nick
Maskell
None available
nick.maskell@bristol.ac.uk
Prof
Nick
Maskell
None available
nick.maskell@bristol.ac.uk
Dr
Steven
Walker
+44 (0)117 4148114
steven.walker@bristol.ac.uk
Secondary spontaneous pneumothorax
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Secondary spontaneous pneumothorax (SSP) is where an abnormal collection of air develops in the space between the lung and the chest wall causing lung collapse. This type of pneumothorax is called secondary as it happens in patients with pre-existing lung conditions such as emphysema and is called spontaneous as it occurs without injury. Currently, SSP is typically treated by inserting a drain into the chest to remove the air. The drain usually stays in place for a week leading to a long hospital stay. A different procedure, needle aspiration, involves inserting a small plastic tube into the chest and removing the air with a syringe over roughly 20 minutes. This is a simpler procedure which means patients may avoid the need to have a chest drain. A previous small study found that patients spent less time in the hospital, and had fewer complications when treated with a needle aspiration. However, because only a small number of people were included in this study, we cannot be completely sure of the results. The PRINCE-SSP study would like to confirm these findings in a bigger study.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/39725415/ (added 17/01/2025)
You can take part if:
You may not be able to take part if:
Patients will be excluded if there is:1. Bilateral pneumothorax2. Traumatic or iatrogenic pneumothorax3. Clinical concerns of tension pneumothorax 4. Age <18 years of age 5. Known pregnancy
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Prof
Nick
Maskell
None available
nick.maskell@bristol.ac.uk
Dr
Steven
Walker
+44 (0)117 4148114
steven.walker@bristol.ac.uk
Dr
Study
Team
None available
prince-ssp@exeter.ac.uk
Prof
Nick
Maskell
None available
nick.maskell@bristol.ac.uk
The study is sponsored by North Bristol NHS Trust and funded by Research for Patient Benefit Programme.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 55271
You can print or share the study information with your GP/healthcare provider or contact the research team directly.